Medicines regulator Swissmedic has approved the booster of the single-dose vaccine from Johnson & Johnson.
“The second dose of the vaccine can be administered, at the earliest, two months after the first dose,” wrote Swissmedic in a statement on Monday.
Swissmedic has also approved the use of Janssen as a booster for mRNA vaccines. It can be administered six months after the second dose of an mRNA vaccine.
“This is the first time in Switzerland that an applicant has submitted clinical data on a mixed vaccination,” wrote Swissmedic.
The Janssen viral vector model vaccine was first approved in March. In September the Swiss government signed a contract to purchase 150,000 doses. The vaccine is based on a human cold virus that contains the blueprint for the “spike” protein of the novel coronavirus.
The other two vaccines approved in Switzerland – Moderna and by Pfizer/BioNTech – use mRNA technology, a process that injects a fragment of the coronavirus blueprint into human cells to prompt the body to produce a defensive response.
Moderna boost
The Swiss government has exercised its option to purchase an additional seven million doses of Moderna’s booster vaccine for delivery in the second half of 2022, the company said on Monday. These vaccine, approved as booster in November, would be in addition to the first seven million doses ordered by the government for 2022. In total, this brings Switzerland’s order to 27.5 million doses of the mRNA vaccine.
Living longer: What do you think about the longevity trend?
The longevity market is booming thanks in part to advances in the science of ageing. What do you think of the idea of significantly extending human lifespan?
This content was published on
Florian Willet was present when the Sarco suicide capsule was first used in Switzerland in September 2024 and had been placed in pre-trial detention.
This content was published on
At the start of the 113th International Labour Conference in Geneva, Houngbo called for a "more efficient" organisation in front of the 187 member states
Microsoft invests $400 million in Swiss AI expansion
This content was published on
Among other things, the existing data centres in the Geneva and Zurich regions are being expanded as part of this investment.
This content was published on
This is the first study first to report a direct interaction between floating plastic debris in the atmosphere and any species.
Delayed flights expected at Geneva airport due to air traffic control issue
This content was published on
Skyguide air traffic control reduced the number of approaches at Geneva Airport by 20% as a precautionary measure for safety reasons.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Swiss regulator approves Pfizer/BioNTech booster for 16 and up
This content was published on
Swissmedic has approved the extension of Covid-19 boosters to all people 16 years of age and over for the Pfizer/BioNTech vaccine.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.